S&P 500   3,225.53 (+0.88%)
DOW   26,833.35 (+0.72%)
QQQ   261.24 (+0.33%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
S&P 500   3,225.53 (+0.88%)
DOW   26,833.35 (+0.72%)
QQQ   261.24 (+0.33%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
S&P 500   3,225.53 (+0.88%)
DOW   26,833.35 (+0.72%)
QQQ   261.24 (+0.33%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
S&P 500   3,225.53 (+0.88%)
DOW   26,833.35 (+0.72%)
QQQ   261.24 (+0.33%)
AAPL   386.61 (-0.42%)
MSFT   205.19 (-1.52%)
GOOGL   1,503.13 (-1.17%)
AMZN   2,987.30 (-3.14%)
NVDA   402.90 (-2.93%)
BABA   247.60 (-0.39%)
TSLA   1,469.99 (-3.09%)
T   30.01 (+0.13%)
DIS   120.33 (+1.41%)
Log in

NASDAQ:EIGREiger Biopharmaceuticals News Headlines

$9.43
-0.04 (-0.42 %)
(As of 07/15/2020 02:45 PM ET)
Add
Compare
Today's Range
$9.30
Now: $9.43
$9.78
50-Day Range
$9.30
MA: $10.70
$13.37
52-Week Range
$4.55
Now: $9.43
$15.82
Volume319,744 shs
Average Volume364,986 shs
Market Capitalization$236.28 million
P/E RatioN/A
Dividend YieldN/A
Beta1.48

Headlines

Eiger Biopharmaceuticals (NASDAQ EIGR) News Headlines

Source:
DateHeadline
Did Hedge Funds Make The Right Call On Eiger BioPharmaceuticals, Inc. (EIGR)Did Hedge Funds Make The Right Call On Eiger BioPharmaceuticals, Inc. (EIGR)
finance.yahoo.com - July 12 at 11:41 PM
Did Hedge Funds Make The Right Call On Eiger BioPharmaceuticals, Inc. (EIGR) ?Did Hedge Funds Make The Right Call On Eiger BioPharmaceuticals, Inc. (EIGR) ?
finance.yahoo.com - July 12 at 11:41 PM
Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) Sees Significant Drop in Short InterestEiger Biopharmaceuticals Inc (NASDAQ:EIGR) Sees Significant Drop in Short Interest
www.americanbankingnews.com - July 9 at 12:05 AM
Eiger BioPharma (EIGR) Upgraded to Strong Buy: What Does It Mean for the Stock?Eiger BioPharma (EIGR) Upgraded to Strong Buy: What Does It Mean for the Stock?
finance.yahoo.com - July 8 at 4:18 PM
Zacks: Analysts Expect Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) Will Post Earnings of -$0.75 Per ShareZacks: Analysts Expect Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) Will Post Earnings of -$0.75 Per Share
www.americanbankingnews.com - July 3 at 3:40 PM
Hedge Funds Stay Consistent On Westwood Holdings Group, Inc. (WHG)Hedge Funds Stay Consistent On Westwood Holdings Group, Inc. (WHG)
finance.yahoo.com - June 25 at 5:44 PM
Why Eiger BioPharmaceuticals (EIGR) Stock Might be a Great PickWhy Eiger BioPharmaceuticals (EIGR) Stock Might be a Great Pick
finance.yahoo.com - June 24 at 10:04 AM
Eiger Biopharmaceuticals Inc (NASDAQ:EIGR) Receives Average Recommendation of "Buy" from AnalystsEiger Biopharmaceuticals Inc (NASDAQ:EIGR) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - June 23 at 5:38 AM
Brokers upbeat on Eiger Biopharmaceuticals Inc despite economic uncertaintyBrokers upbeat on Eiger Biopharmaceuticals Inc despite economic uncertainty
uk.finance.yahoo.com - June 10 at 8:23 AM
Hedge Funds Can’t Buy Enough Of Eiger BioPharmaceuticals, Inc. (EIGR)Hedge Funds Can’t Buy Enough Of Eiger BioPharmaceuticals, Inc. (EIGR)
finance.yahoo.com - June 8 at 1:40 PM
Eiger BioPharmaceuticals, Inc. to Hold Virtual Annual Meeting of Stockholders on June 15, 2020Eiger BioPharmaceuticals, Inc. to Hold Virtual Annual Meeting of Stockholders on June 15, 2020
finance.yahoo.com - May 29 at 8:22 PM
Eiger to Present at Jefferies Virtual Healthcare Conference 2020Eiger to Present at Jefferies Virtual Healthcare Conference 2020
finance.yahoo.com - May 26 at 6:40 PM
FDA accepts Eiger Bio application for lonafarnib for rare aging disorderFDA accepts Eiger Bio application for lonafarnib for rare aging disorder
seekingalpha.com - May 19 at 8:24 PM
Eiger BioPharmaceuticals Announces FDA Acceptance of NDA for Filing with Priority Review of Zokinvy™ (lonafarnib) for Treatment of Progeria and Progeroid LaminopathiesEiger BioPharmaceuticals Announces FDA Acceptance of NDA for Filing with Priority Review of Zokinvy™ (lonafarnib) for Treatment of Progeria and Progeroid Laminopathies
finance.yahoo.com - May 19 at 8:24 PM
Analysts optimistic on Eiger Biopharmaceuticals Inc outlookAnalysts optimistic on Eiger Biopharmaceuticals Inc outlook
uk.finance.yahoo.com - May 19 at 10:23 AM
Is Eiger BioPharmaceuticals (EIGR) Stock a Solid Choice Right Now?Is Eiger BioPharmaceuticals (EIGR) Stock a Solid Choice Right Now?
finance.yahoo.com - May 15 at 10:04 AM
Eiger BioPharmaceuticals: Promising COVID-19 Effort With Peginterferon Lambda Just Entering Clinical TrialsEiger BioPharmaceuticals: Promising COVID-19 Effort With Peginterferon Lambda Just Entering Clinical Trials
seekingalpha.com - May 8 at 4:17 PM
Eiger BioPharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business UpdateEiger BioPharmaceuticals Reports First Quarter 2020 Financial Results and Provides Business Update
www.prnewswire.com - May 7 at 4:28 PM
Dosing underway in study of Eigers peginterferon lambda in COVID-19Dosing underway in study of Eiger's peginterferon lambda in COVID-19
seekingalpha.com - April 30 at 4:08 PM
Eiger BioPharmaceuticals Announces First COVID-19 Patients Dosed with Peginterferon LambdaEiger BioPharmaceuticals Announces First COVID-19 Patients Dosed with Peginterferon Lambda
finance.yahoo.com - April 30 at 4:08 PM
EMA accepts Eiger Bio application for lonafarnib for rare premature aging disorderEMA accepts Eiger Bio application for lonafarnib for rare premature aging disorder
seekingalpha.com - April 27 at 1:34 PM
Eiger BioPharmaceuticals Announces EMA Validation of Lonafarnib MAA for Treatment of Progeria and Progeroid LaminopathiesEiger BioPharmaceuticals Announces EMA Validation of Lonafarnib MAA for Treatment of Progeria and Progeroid Laminopathies
www.prnewswire.com - April 27 at 8:34 AM
Will Eiger BioPharmaceuticals Continue to Surge Higher?Will Eiger BioPharmaceuticals Continue to Surge Higher?
finance.yahoo.com - April 22 at 11:12 AM
Coronavirus pandemic issues delay key Eiger BioPharma studyCoronavirus pandemic issues delay key Eiger BioPharma study
seekingalpha.com - April 1 at 4:59 PM
Eiger BioPharmaceuticals Provides Update on Clinical Development Activities and Business Operations During COVID-19 PandemicEiger BioPharmaceuticals Provides Update on Clinical Development Activities and Business Operations During COVID-19 Pandemic
finance.yahoo.com - April 1 at 4:59 PM
Eiger Completes NDA Submission of Progeria Drug LonafarnibEiger Completes NDA Submission of Progeria Drug Lonafarnib
finance.yahoo.com - March 24 at 2:31 PM
Eiger Bio completes NDA submission for lonafarnibEiger Bio completes NDA submission for lonafarnib
seekingalpha.com - March 23 at 8:41 AM
Eiger BioPharmaceuticals Completes Submission of New Drug Application to FDA for Lonafarnib for Treatment of Progeria and Progeroid LaminopathiesEiger BioPharmaceuticals Completes Submission of New Drug Application to FDA for Lonafarnib for Treatment of Progeria and Progeroid Laminopathies
finance.yahoo.com - March 23 at 8:41 AM
Insider Buying: The Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Founder Just Bought US$151k Worth Of SharesInsider Buying: The Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Founder Just Bought US$151k Worth Of Shares
finance.yahoo.com - March 20 at 7:43 AM
Eiger BioPharmaceuticals EPS beats by $0.13Eiger BioPharmaceuticals EPS beats by $0.13
seekingalpha.com - March 13 at 8:43 AM
Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business UpdateEiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
finance.yahoo.com - March 13 at 8:43 AM
Evaluating Eiger BioPharmaceuticalsEvaluating Eiger BioPharmaceuticals
seekingalpha.com - February 18 at 10:26 PM
Trade Alert: The Chairman Of Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR), Thomas Dietz, Has Just Spent US$56k Buying SharesTrade Alert: The Chairman Of Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR), Thomas Dietz, Has Just Spent US$56k Buying Shares
finance.yahoo.com - January 15 at 8:44 AM
Eiger BioPharmaceuticals Appoints Industry Veteran Eldon Mayer as Executive Vice President and Chief Commercial OfficerEiger BioPharmaceuticals Appoints Industry Veteran Eldon Mayer as Executive Vice President and Chief Commercial Officer
finance.yahoo.com - January 7 at 10:38 AM
Eiger Updates on 2019 Progress and 2020 Milestones ExpectedEiger Updates on 2019 Progress and 2020 Milestones Expected
finance.yahoo.com - January 6 at 5:24 PM
Eiger Bio launches rolling submission of lonafarnib NDA for progeriaEiger Bio launches rolling submission of lonafarnib NDA for progeria
seekingalpha.com - December 16 at 11:20 PM
Eiger Initiates Rolling Submission of New Drug Application (NDA) with FDA for Lonafarnib for Treatment of Progeria and Progeroid LaminopathiesEiger Initiates Rolling Submission of New Drug Application (NDA) with FDA for Lonafarnib for Treatment of Progeria and Progeroid Laminopathies
finance.yahoo.com - December 16 at 6:19 PM
Eiger BioPharmaceuticalsEiger BioPharmaceuticals
www.fool.com - November 21 at 10:07 PM
Eiger to Present at Jefferies 2019 London Healthcare ConferenceEiger to Present at Jefferies 2019 London Healthcare Conference
finance.yahoo.com - November 15 at 12:32 PM
Eiger Announces Peginterferon Lambda - Lonafarnib...Eiger Announces Peginterferon Lambda - Lonafarnib...
www.benzinga.com - November 12 at 12:24 PM
Eiger BioPharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business UpdateEiger BioPharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - November 7 at 6:55 PM
Eiger Announces Peginterferon Lambda Combination Therapy for Treatment of Chronic Hepatitis Delta Virus (HDV) Infection to be Featured in a Late-Breaking Oral Presentation at AASLD 2019Eiger Announces Peginterferon Lambda Combination Therapy for Treatment of Chronic Hepatitis Delta Virus (HDV) Infection to be Featured in a Late-Breaking Oral Presentation at AASLD 2019
finance.yahoo.com - November 1 at 9:26 AM
Do Institutions Own Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Shares?Do Institutions Own Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) Shares?
finance.yahoo.com - October 9 at 12:31 PM
Eiger to Present at Cantor 2019 Global Healthcare ConferenceEiger to Present at Cantor 2019 Global Healthcare Conference
finance.yahoo.com - September 27 at 5:21 PM
Eiger BioPharmaceuticals to Participate in September ConferencesEiger BioPharmaceuticals to Participate in September Conferences
finance.yahoo.com - August 29 at 8:12 PM
Eiger up 3% premarket on BTD tag for peginterferon lambda for HDV infectionEiger up 3% premarket on BTD tag for peginterferon lambda for HDV infection
seekingalpha.com - August 20 at 11:08 AM
Eiger Announces FDA Breakthrough Therapy Designation for Peginterferon Lambda for Treatment of Hepatitis Delta Virus InfectionEiger Announces FDA Breakthrough Therapy Designation for Peginterferon Lambda for Treatment of Hepatitis Delta Virus Infection
finance.yahoo.com - August 20 at 11:08 AM
Eiger BioPharmaceuticals EPS beats by $0.01Eiger BioPharmaceuticals EPS beats by $0.01
seekingalpha.com - August 9 at 9:09 AM
Eiger BioPharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business UpdateEiger BioPharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - August 9 at 9:09 AM
Eiger BioPharmaceuticals to Participate in Investor Conferences in AugustEiger BioPharmaceuticals to Participate in Investor Conferences in August
finance.yahoo.com - August 5 at 9:09 AM
This page was last updated on 7/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.